亿胜生物科技有限公司（01061）于2026年2月3日提交2026年1月股份变动月报表。报告显示，截至本月，无新增股份发行、购回或注销，整体股本情况保持稳定。
公司已注册股本为10亿股普通股，每股面值0.1港元；注册股本总额为1亿港元。报告期内，截至1月31日，已发行股份数维持在567,006,000股，库存股份为零，无任何变动。
公司同时披露一项于2023年6月9日举行股东大会通过的购股权计划，可针对57,064,900股进行行使，但本月未有实质发股或转让操作，亦无购回或注销活动。公司表示相关公众持股量符合香港联交所主板上市规则的最低要求。
公告由董事方海洲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.